Open-label, Phase 2 Clinical Trial of Crizotinib for Children and Adults with Neurofibromatosis Type 2 and Progressive ... Clinical response will be assessed by MRI (volumetrics, primary objective) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback